publication date: Jun. 28, 2019

Conversation with The Cancer Letter

MD Anderson: We cooperated fully with CMS and implemented changes into our clinical practice

 Hahn_Stephen[1]

Stephen Hahn

Chief medical executive,

MD Anderson Cancer Center 

 

 Morris_Rosanna[1]

Rosanna Morris

Chief operating officer,

MD Anderson Cancer Center

 

After a 23 year-old patient at MD Anderson Cancer Center died from complications stemming from a platelet transfusion that was contaminated with gram negative coccobacilli, hospital officials are revising internal protocols to demonstrate compliance with federal regulations.

MD Anderson reported the incident to FDA in December 2018. As a result of the report, the Centers for Medicare and Medicaid Services conducted a survey, finding deficiencies in patient care and removing MD Anderson’s Medicare “deemed” status. On June 21, the cancer center submitted a “plan of correction” to seek reinstatement of that status.

“While it is unfortunate that the CMS surveys resulted from a patient’s death, we recognize and embrace the opportunity to further enhance and improve our patient care efforts and robust safety measures,” said Stephen Hahn, chief medical executive at MD Anderson. … Continue reading MD Anderson: We cooperated fully with CMS and implemented changes into our clinical practice

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.